Search Results - Leisha A Emens
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
It’s TIME for a biomarker-driven approach to cancer immunotherapy by Leisha A Emens
Published 2016-06-01
Article -
2
Targeting adenosine for cancer immunotherapy by Robert D. Leone, Leisha A. Emens
Published 2018-06-01
Article -
3
-
4
-
5
Advances and challenges in cancer immunoprevention and immune interception by Leisha A Emens, Sasha E Stanton, Philip E Castle, Shizuko Sei, Olivera J Finn
Published 2024-03-01
Article -
6
-
7
788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head... by Jeffrey Schlom, Leisha A Emens, Howard Kaufman, James Hodge, Sailaja Battula, Kellsye Fabian, Ginette Santiago-Sanchez
Published 2023-11-01Article -
8
-
9
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis by Fausto Petrelli, Valentina Bertaglia, Maria Chiara Parati, Karen Borgonovo, Pushpamali De Silva, Andrea Luciani, Silvia Novello, Mario Scartozzi, Leisha A. Emens, Cinzia Solinas
Published 2023-02-01
Article -
10
Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice by Joyce O’Shaughnessy, Leisha A. Emens, Stephen Y. Chui, Wei Wang, Kenneth Russell, Shih-Wen Lin, Carlos Flores Avile, Patricia Luhn, Andreas Schneeweiss
Published 2021-07-01
Article -
11
Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab by Luciana Molinero, Yijin Li, Ching-Wei Chang, Sophia Maund, Maureen Berg, Jeanne Harrison, Marcella Fassò, Carol O’Hear, Priti Hegde, Leisha A. Emens
Published 2019-10-01
Article -
12
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision by James L Gulley, Deborah Collyar, Pedro J Romero, Christian M Capitini, Leisha A Emens, Avery D Posey, Patrick Hwu, Jennifer A Wargo, Ann W Silk, Ana Carrizosa Anderson, Tullia C Bruno
Published 2024-06-01
Article -
13
Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer by Haoyang Mi, Chang Gong, Jeremias Sulam, Jeremias Sulam, Elana J. Fertig, Elana J. Fertig, Alexander S. Szalay, Alexander S. Szalay, Elizabeth M. Jaffee, Elizabeth M. Jaffee, Vered Stearns, Leisha A. Emens, Ashley M. Cimino-Mathews, Ashley M. Cimino-Mathews, Aleksander S. Popel, Aleksander S. Popel
Published 2020-10-01
Article -
14
Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers by Pooja Srivastava, Tiannan Wang, Beth Z. Clark, Jing Yu, Jeffrey L. Fine, Tatiana M. Villatoro, Gloria J. Carter, Adam M. Brufsky, Vikram C. Gorantla, Shannon L. Huggins-Puhalla, Leisha A. Emens, Thais Basili, Edaise M. da Silva, Jorge S. Reis-Filho, Rohit Bhargava
Published 2022-04-01
Article -
15
Development of [F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide by Wojciech G. Lesniak PhD, Ronnie C. Mease PhD, Samit Chatterjee PhD, Dhiraj Kumar PhD, Ala Lisok MA, Bryan Wharram MS, Venkateswara Rao Kalagadda PhD, Leisha A. Emens MD, PhD, Martin G. Pomper MD, PhD, Sridhar Nimmagadda PhD
Published 2019-06-01
Article -
16
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy) by Paolo A. Ascierto, Carlo Bifulco, Fortunato Ciardiello, Sandra Demaria, Leisha A. Emens, Robert Ferris, Silvia C. Formenti, Jerome Galon, Samir N. Khleif, Tomas Kirchhoff, Jennifer McQuade, Kunle Odunsi, Akash Patnaik, Chrystal M. Paulos, Janis M. Taube, John Timmerman, Bernard A. Fox, Patrick Hwu, Igor Puzanov
Published 2021-06-01
Article -
17
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge” (December 4th–5th, 2019, Naples, Italy) by Paolo A. Ascierto, Lisa H. Butterfield, Katie Campbell, Bruno Daniele, Michael Dougan, Leisha A. Emens, Silvia Formenti, Filip Janku, Samir N. Khleif, Tomas Kirchhoff, Alessandro Morabito, Yana Najjar, Paul Nathan, Kunle Odunsi, Akash Patnaik, Chrystal M. Paulos, Bradley I. Reinfeld, Heath D. Skinner, John Timmerman, Igor Puzanov
Published 2021-01-01
Article -
18
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer by Sara M Tolaney, Leisha A Emens, Mary L Disis, David B Page, Heather L McArthur, Ashley Cimino-Mathews, Sylvia Adams, Elizabeth A Mittendorf, Rita Nanda, Hope S Rugo, Margaret E Gatti-Mays, Krista M Rubin, Alice Y Ho, Kevin Kalinsky, Hatem Soliman, Patricia A Spears, Jennifer K Litton
Published 2021-08-01
Article -
19
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC) by James L Gulley, James Larkin, Leisha A Emens, Mario Sznol, Madhav Dhodapkar, Daniel S Chen, Roy S Herbst, Tim F Greten, Robert L Ferris, Luca Mazzarella, Paolo A Ascierto, Marc S Ernstoff, Michael B Atkins, Kim A Margolin, Brian I Rini, Michael R Bishop, Suresh S Ramalingam, Meredith M Regan, Rachel W Humphrey
Published 2022-09-01
Article -
20
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy) by Paolo A. Ascierto, Carlo Bifulco, Luigi Buonaguro, Leisha A. Emens, Robert L. Ferris, Bernard A. Fox, Greg M. Delgoffe, Jérôme Galon, Cesare Gridelli, Marco Merlano, Paul Nathan, Kunle Odunsi, Hideho Okada, Chrystal M. Paulos, Sandro Pignata, Kurt A. Schalper, Stefani Spranger, Giampaolo Tortora, Hassane Zarour, Lisa H. Butterfield, Igor Puzanov
Published 2019-11-01
Article